Treatment of uncooperative psychiatric patients in the community

Search for Gamma-Ray Spectral Lines from Dark Matter Annihilation with the H.E.S.S. Inner Galaxy Survey.

Physical review letters·2026

High-Statistics Measurement of the Cosmic-Ray Electron Spectrum with H.E.S.S.

Physical review letters·2024

Two risk assessments: Evaluating the use of indicator HF183 Bacteroides versus pathogen measurements for modelling recreational illness risks in an urban watershed.

Water research·2024

Acceleration and transport of relativistic electrons in the jets of the microquasar SS 433.

Science (New York, N.Y.)·2024

Academic clinician frontline-worker wellbeing and resilience during the COVID-19 pandemic experience: Were there gender differences?

Preventive medicine reports·2023

Factor structure of the Oxford Shoulder Score: secondary analyses of the UK FROST and PROFHER trial populations.

Journal of orthopaedic surgery and research·2023

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Prevalence and sociodemographic correlates of mental and behavioural disorders in Pakistan: findings from the first nationally representative cross-sectional survey.

BMJ public health·2026

Rimegepant for vestibular and cochlear symptoms associated with vertigo in a real-world retrospective study.

iScience·2026

Recounting Workforce: The Impact of Multi-licensure on Behavioral Health Provider Estimates.

The journal of behavioral health services & research·2026

A comparison of a novel neuropsychological screening tool with provider recommendations among pediatric cancer survivors.

Journal of cancer survivorship : research and practice·2026

EHR-based machine learning for psychiatric outcomes in youth and young adults: Challenges and opportunities.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026

Association of social determinants of health with opioid misuse among individuals with common psychiatric conditions.

Psychiatry research communications·2026

Related Experiment Videos

Treatment of uncooperative psychiatric patients in the community

Related Concept Videos

Search for Gamma-Ray Spectral Lines from Dark Matter Annihilation with the H.E.S.S. Inner Galaxy Survey.

High-Statistics Measurement of the Cosmic-Ray Electron Spectrum with H.E.S.S.

Two risk assessments: Evaluating the use of indicator HF183 Bacteroides versus pathogen measurements for modelling recreational illness risks in an urban watershed.

Acceleration and transport of relativistic electrons in the jets of the microquasar SS 433.

Academic clinician frontline-worker wellbeing and resilience during the COVID-19 pandemic experience: Were there gender differences?

Factor structure of the Oxford Shoulder Score: secondary analyses of the UK FROST and PROFHER trial populations.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Prevalence and sociodemographic correlates of mental and behavioural disorders in Pakistan: findings from the first nationally representative cross-sectional survey.

Rimegepant for vestibular and cochlear symptoms associated with vertigo in a real-world retrospective study.

Recounting Workforce: The Impact of Multi-licensure on Behavioral Health Provider Estimates.

A comparison of a novel neuropsychological screening tool with provider recommendations among pediatric cancer survivors.

EHR-based machine learning for psychiatric outcomes in youth and young adults: Challenges and opportunities.

Association of social determinants of health with opioid misuse among individuals with common psychiatric conditions.

Related Experiment Videos

Treatment of uncooperative psychiatric patients in the community

Related Concept Videos

Related Articles